— Know what they know.
Not Investment Advice

MTLS

Materialise N.V.
1W: -1.8% 1M: -9.9% 3M: -14.7% YTD: -11.9% 1Y: -7.0% 3Y: -37.4% 5Y: -88.3%
$4.80
-0.14 (-2.83%)
After Hours: $5.03 (+0.23, +4.79%)
Weekly Expected Move ±3.7%
$4 $5 $5 $5 $5
NASDAQ · Technology · Software - Application · $283.5M · Alpha Radar Sell · Power 43
Smart Money Score
Watch 25
Insider
Congress
ETF Holdings
Key Statistics
Market Cap$283.5M
52W Range3.93-6.8
Volume75,143
Avg Volume130,196
Beta1.23
Dividend
Analyst Ratings
8 Buy 4 Hold 0 Sell
Consensus Buy
Company Info
CEOBrigitte de Vet-Veithen
Employees488
SectorTechnology
IndustrySoftware - Application
IPO Date2014-06-25
Technologielaan 15
Leuven 3001
BE
32 1 639 66 11
About Materialise N.V.

Materialise NV provides additive manufacturing and medical software, and 3D printing services in the Americas, Europe and Africa, and the Asia-Pacific. The company operates through three segments: Materialise Software, Materialise Medical, and Materialise Manufacturing. Its Materialise Software segment offers software through programs and platforms that enable and enhance the functionality of 3D printers and of 3D printing operations. Its software interfaces between various types of 3D printers; and various software applications and capturing technologies, including computer-aided design/computer-aided manufacturing packages and 3D scanners. This segment serves 3D printing machine manufacturers; production companies and contract manufacturers in automotive, aerospace, consumer goods, and hearing aid industries; and 3D printing service bureaus through its sales force, Website, and third-party distributors. The company's Materialise Medical segment provides medical software that allows medical-image based analysis and engineering, as well as patient-specific design of surgical devices and implants. It serves medical device companies, hospitals, universities, research institutes, and industrial companies through its direct sales force, Website, and picture archiving and communication system partners. Its Materialise Manufacturing segment provides 3D printing services, design and engineering services, and rapid prototyping and additive manufacturing of production parts to industrial and commercial customers. The company has collaboration agreements with Zimmer Biomet Holdings, Inc.; Encore Medical, L.P.; DePuy Synthes Companies of Johnson & Johnson; Limacorporate Spa; Mathys AG; Corin Ltd; Medtronic Inc.; and Abbott Laboratories Inc. Materialise NV was incorporated in 1990 and is headquartered in Leuven, Belgium.

Recent Insider Trades

No insider trades found

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms